Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

NCT06065046 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Traumatic Brain Injury

Interventions

DRUG: Baricitinib 4 MG
OTHER: Standard treatment

Sponsor

Tang-Du Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]